- Home
- MULN vs SPRC Comparison
MULN vs SPRC Comparison
Compare MULN & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MULN
- SPRC
- Stock Information
- Founded
- MULN 2014
- SPRC 2004
- Country
- MULN United States
- SPRC Israel
- Employees
- MULN N/A
- SPRC N/A
- Industry
- MULN Auto Manufacturing
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- MULN Consumer Discretionary
- SPRC Health Care
- Exchange
- MULN Nasdaq
- SPRC Nasdaq
- Market Cap
- MULN 6.5M
- SPRC 3.4M
- IPO Year
- MULN N/A
- SPRC N/A
- Fundamental
- Price
- MULN $0.27
- SPRC $0.31
- Analyst Decision
- MULN
- SPRC
- Analyst Count
- MULN 0
- SPRC 0
- Target Price
- MULN N/A
- SPRC N/A
- AVG Volume (30 Days)
- MULN 10.6M
- SPRC 200.9K
- Earning Date
- MULN 08-11-2025
- SPRC 02-15-2025
- Dividend Yield
- MULN N/A
- SPRC N/A
- EPS Growth
- MULN N/A
- SPRC N/A
- EPS
- MULN N/A
- SPRC N/A
- Revenue
- MULN $8,931,612.00
- SPRC $1,306,000.00
- Revenue This Year
- MULN N/A
- SPRC N/A
- Revenue Next Year
- MULN N/A
- SPRC N/A
- P/E Ratio
- MULN N/A
- SPRC N/A
- Revenue Growth
- MULN 2136.62
- SPRC N/A
- 52 Week Low
- MULN $0.25
- SPRC $0.20
- 52 Week High
- MULN $150,000,000.00
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- MULN 17.40
- SPRC 49.26
- Support Level
- MULN $1.62
- SPRC $0.29
- Resistance Level
- MULN $1.64
- SPRC $0.32
- Average True Range (ATR)
- MULN 0.46
- SPRC 0.02
- MACD
- MULN 111.81
- SPRC -0.00
- Stochastic Oscillator
- MULN 0.56
- SPRC 40.60
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and building energy solutions. Its portfolio of vehicles is predominantly comprised of commercial trucks and other electric vehicles and includes; Mullen Class 1 Cargo Van, Mullen Three, Bollinger B4 Chassis Cab, and Mullen I-GO. The company's operating segments are Bollinger which derives maximum revenue, and Mullen Commercial.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.